ahlam1399
05-29-2015, 02:31 AM
U.S. court grants exclusivity for Amarin?s Vascepa
(Reuters) - A U.S. district court has ruled that Amarin Corp's fish oil pill, Vascepa, is eligible for five years of marketing exclusivity, setting aside a U.S. Food and Drug administration decision.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bbf46e/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=FBJczULG0bU:bv5fXhshPco:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=FBJczULG0bU:bv5fXhshPco:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/FBJczULG0bU
(Reuters) - A U.S. district court has ruled that Amarin Corp's fish oil pill, Vascepa, is eligible for five years of marketing exclusivity, setting aside a U.S. Food and Drug administration decision.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bbf46e/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=FBJczULG0bU:bv5fXhshPco:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=FBJczULG0bU:bv5fXhshPco:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=FBJczULG0bU:bv5fXhshPco:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/FBJczULG0bU